Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Retained Earnings (2018 - 2026)

Profound Medical has reported Retained Earnings over the past 8 years, most recently at $5.0 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 102.05% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, up 102.05%, while the annual FY2025 figure was $5.0 million, 102.05% up from the prior year.
  • Retained Earnings for Q4 2025 was $5.0 million at Profound Medical, up from $4.8 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $16.8 billion in Q1 2023 and troughed at -$271.6 million in Q2 2025.
  • A 5-year average of $909.6 million and a median of $1.7 million in 2021 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: tumbled 4587215.04% in 2021 and later surged 584.47% in 2023.
  • Year by year, Retained Earnings stood at -$160.7 million in 2021, then fell by 17.84% to -$189.4 million in 2022, then decreased by 14.78% to -$217.4 million in 2023, then fell by 12.8% to -$245.2 million in 2024, then soared by 102.05% to $5.0 million in 2025.
  • Business Quant data shows Retained Earnings for PROF at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and -$271.6 million in Q2 2025.